BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Covington
Express Scripts
McKesson
Argus Health
US Department of Justice
Daiichi Sankyo
Merck
QuintilesIMS
Mallinckrodt

Generated: January 22, 2018

DrugPatentWatch Database Preview

Hydralazine hydrochloride; hydrochlorothiazide; reserpine - Generic Drug Details

« Back to Dashboard

What are the generic sources for hydralazine hydrochloride; hydrochlorothiazide; reserpine and what is the scope of hydralazine hydrochloride; hydrochlorothiazide; reserpine patent protection?

Hydralazine hydrochloride; hydrochlorothiazide; reserpine
is the generic ingredient in twelve branded drugs marketed by Chartwell Rx, Ivax Sub Teva Pharms, Mylan, Watson Labs, Sandoz, Solvay, Sun Pharm Industries, Lederle, and Novartis, and is included in sixteen NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty drug master file entries for hydralazine hydrochloride; hydrochlorothiazide; reserpine.
Summary for hydralazine hydrochloride; hydrochlorothiazide; reserpine

US Patents and Regulatory Information for hydralazine hydrochloride; hydrochlorothiazide; reserpine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Solvay UNIPRES hydralazine hydrochloride; hydrochlorothiazide; reserpine TABLET;ORAL 085893-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs RESERPINE, HYDRALAZINE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE hydralazine hydrochloride; hydrochlorothiazide; reserpine TABLET;ORAL 085549-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz HYDRAP-ES hydralazine hydrochloride; hydrochlorothiazide; reserpine TABLET;ORAL 084876-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan HYDRALAZINE HYDROCHLORIDE-HYDROCHLOROTHIAZIDE-RESERPINE hydralazine hydrochloride; hydrochlorothiazide; reserpine TABLET;ORAL 087085-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Novartis SER-AP-ES hydralazine hydrochloride; hydrochlorothiazide; reserpine TABLET;ORAL 012193-005 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sun Pharm Industries RESERPINE, HYDRALAZINE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE hydralazine hydrochloride; hydrochlorothiazide; reserpine TABLET;ORAL 088570-001 Apr 10, 1984 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs HYDRALAZINE, HYDROCHLOROTHIAZIDE W/ RESERPINE hydralazine hydrochloride; hydrochlorothiazide; reserpine TABLET;ORAL 085771-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Chartwell Rx CAM-AP-ES hydralazine hydrochloride; hydrochlorothiazide; reserpine TABLET;ORAL 084897-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Solvay UNIPRES hydralazine hydrochloride; hydrochlorothiazide; reserpine TABLET;ORAL 086298-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Solvay SER-A-GEN hydralazine hydrochloride; hydrochlorothiazide; reserpine TABLET;ORAL 087210-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Express Scripts
Chinese Patent Office
Novartis
Teva
Julphar
US Army
UBS
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot